Activation of ion transport by combined effects of ionomycin, forskolin and phorbol ester on cultured HT-29cl.19A human colonocytes

Pflugers Arch. 1993 Oct;425(1-2):90-9. doi: 10.1007/BF00374508.

Abstract

The differentiated clone 19A of the HT-29 human colon carcinoma cell line was used as a model to study the intracellular electrophysiological effects of interaction of the cAMP, the protein kinase C (PKC) and the Ca2+ pathways. (a) A synergistic effect between ionomycin and forskolin was observed. From intracellular responses it was concluded that the synergistic effect is caused by activation of an apical Cl- conductance by protein kinase A and a basolateral K+ conductance by Ca2+. (b) A transient synergistic effect of ionomycin and the phorbol ester phorbol dibutyrate (PDB) was found. The decrease of the response appeared to be due to PKC-dependent inactivation of the basolateral K+ conductance. The synergism is caused by PKC-dependent increase of the apical Cl- conductance and Ca(2+)-dependent increase of the basolateral K+ conductance. (c) The effects of carbachol and PDB were not fully additive presumably because of their convergence on PKC activation. (d) Forskolin and PDB, when added in this order, had a less than additive effect. Results of cell-attached patch-clamp studies, presented in the accompanying paper, showed a synergistic effect of forskolin and PDB on non-rectifying small-conductance Cl- channels. Assuming that these channels are involved in the transepithelial responses it is suggested that forskolin and PDB induce a modulatory, synergistic increase of the apical Cl- conductance when both pathways are activated simultaneously. (e) The HT-29cl.19A cells differ from T84 cells in that the latter did n ot respond with an increase of the short-circuit current to addition of phorbol ester. this may be due to a very low expression of PKA alpha.

MeSH terms

  • Biological Transport / drug effects
  • Calcium / metabolism
  • Calcium / pharmacology
  • Carbachol / pharmacology
  • Chloride Channels / physiology*
  • Colforsin / pharmacology*
  • Colonic Neoplasms / metabolism*
  • Cyclic AMP / physiology
  • Drug Synergism
  • Electric Conductivity
  • Humans
  • Ionomycin / pharmacology*
  • Phorbol 12,13-Dibutyrate / pharmacology*
  • Potassium Channels / physiology*
  • Protein Kinase C / metabolism
  • Tumor Cells, Cultured

Substances

  • Chloride Channels
  • Potassium Channels
  • Colforsin
  • Phorbol 12,13-Dibutyrate
  • Ionomycin
  • Carbachol
  • Cyclic AMP
  • Protein Kinase C
  • Calcium